186 related articles for article (PubMed ID: 35595823)
1. STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment.
Anderson K; Ryan N; Nedungadi D; Lamenza F; Swingler M; Siddiqui A; Satoskar A; Upadhaya P; Pietrzak M; Oghumu S
Br J Cancer; 2022 Sep; 127(4):624-636. PubMed ID: 35595823
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma.
Ma H; Yang W; Zhang L; Liu S; Zhao M; Zhou G; Wang L; Jin S; Zhang Z; Hu J
Br J Cancer; 2019 Feb; 120(3):317-330. PubMed ID: 30555157
[TBL] [Abstract][Full Text] [Related]
3. STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma.
Ryan N; Anderson K; Volpedo G; Hamza O; Varikuti S; Satoskar AR; Oghumu S
Int J Cancer; 2020 Mar; 146(6):1717-1729. PubMed ID: 31709529
[TBL] [Abstract][Full Text] [Related]
4. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y
Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215
[No Abstract] [Full Text] [Related]
5. A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma.
Ma H; Chang H; Yang W; Lu Y; Hu J; Jin S
Mol Cancer; 2020 Jan; 19(1):4. PubMed ID: 31907020
[TBL] [Abstract][Full Text] [Related]
6. TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
Mao L; Xiao Y; Yang QC; Yang SC; Yang LL; Sun ZJ
Oral Oncol; 2021 Oct; 121():105472. PubMed ID: 34333450
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma.
Ma H; Jin S; Yang W; Zhou G; Zhao M; Fang S; Zhang Z; Hu J
Br J Cancer; 2018 Feb; 118(4):509-521. PubMed ID: 29348488
[TBL] [Abstract][Full Text] [Related]
8. Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma.
Knitz MW; Darragh LB; Bickett TE; Bhatia S; Bukkapatnam S; Gadwa J; Piper M; Corbo S; Nguyen D; Van Court B; Oweida A; Karam SD
Cancer Immunol Immunother; 2022 May; 71(5):1049-1061. PubMed ID: 34559306
[TBL] [Abstract][Full Text] [Related]
9. E3 Ubiquitin Ligase RNF125 Suppresses Immune Escape in Head and Neck Squamous Cell Carcinoma by Regulating PD-L1 Expression.
Jiang C; He L; Xiao S; Wu W; Zhao Q; Liu F
Mol Biotechnol; 2023 Jun; 65(6):891-903. PubMed ID: 36344734
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous disturbance of NHE1 and LOXL2 decreases tumorigenicity of head and neck squamous cell carcinoma.
Hayashi Y; Miyoshi S; Watanabe I; Yano N; Nagashio K; Kaneko M; Kaminota T; Sanada T; Hosokawa Y; Kitani T; Mitani S; Choudhury ME; Yano H; Tanaka J; Hato N
Auris Nasus Larynx; 2024 Jun; 51(3):472-480. PubMed ID: 38520980
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma.
Mann JE; Smith JD; Kulkarni A; Foltin SK; Scheftz EB; Murray IR; Gensterblum-Miller E; Brummel CV; Bhangale A; Hoesli RC; Brenner JC
Oral Oncol; 2023 Nov; 146():106562. PubMed ID: 37666053
[TBL] [Abstract][Full Text] [Related]
12. Black raspberry extract inhibits regulatory T-cell activity in a murine model of head and neck squamous cell carcinoma chemoprevention.
Ryan NM; Lamenza FF; Upadhaya P; Pracha H; Springer A; Swingler M; Siddiqui A; Oghumu S
Front Immunol; 2022; 13():932742. PubMed ID: 36016924
[TBL] [Abstract][Full Text] [Related]
13. HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings.
Boschert V; Teusch J; Aljasem A; Schmucker P; Klenk N; Straub A; Bittrich M; Seher A; Linz C; Müller-Richter UDA; Hartmann S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233528
[TBL] [Abstract][Full Text] [Related]
14. The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling.
Tsai MS; Chen WC; Lu CH; Chen MF
Oral Oncol; 2019 Apr; 91():47-55. PubMed ID: 30926062
[TBL] [Abstract][Full Text] [Related]
15. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
Wu Q; Zhao Y; Sun Y; Yan X; Wang P
Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
[TBL] [Abstract][Full Text] [Related]
16. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
[TBL] [Abstract][Full Text] [Related]
17. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
Hira-Miyazawa M; Nakamura H; Hirai M; Kobayashi Y; Kitahara H; Bou-Gharios G; Kawashiri S
Int J Oncol; 2018 Feb; 52(2):379-388. PubMed ID: 29345283
[TBL] [Abstract][Full Text] [Related]
18. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
[TBL] [Abstract][Full Text] [Related]
19. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer.
Han N; Zhou D; Ruan M; Yan M; Zhang C
Oral Oncol; 2023 Oct; 145():106524. PubMed ID: 37482043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
